Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Michael Horton

2106 posts
Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • News

United Airlines Is Nearing Deal For More Than 100 Widebody Jets

By Michael Horton
October 13, 5:34 PM
-Bloomberg

UAL

Read More
1 minute read
  • News

Westlake Set To Join S&P MidCap 400, Replacing MillerKnoll; MillerKnoll To Replace Covetrus In S&P SmallCap 600

By Michael Horton
October 13, 5:23 PM
Westlake Corp. (NYSE:WLK) will replace MillerKnoll Inc. (NASD:MLKN) in the S&P MidCap 400, and MillerKnoll will replace Covetrus Inc. (NASD:CVET) in the S&P SmallCap 600 effective prior to the opening of trading on Tuesday, October 18.

CVET

Read More
1 minute read
  • General
  • Health Care
  • News

U.S. Supreme Court Lifts Block On Generic Version Of Novartis Blockbuster Multiple Sclerosis Drug

By Michael Horton
October 13, 5:16 PM
-Reuters

NVS

Read More
1 minute read
  • News

‘Take-Two Is Shutting New York Studio Behind Popular Mobile Game Dots’ -Bloomberg

By Michael Horton
October 13, 5:14 PM
https://www.bloomberg.com/news/articles/2022-10-13/take-two-shuts-playdots-game-studio-in-new-york-cutting-65-jobs?sref=DWzi38c2

TTWO

Read More
1 minute read
  • Contracts
  • News

Oceaneering Wins $300M Of Subsea Robotics Contracts During Q3’22

By Michael Horton
October 13, 5:02 PM
Oceaneering International, Inc. (NYSE:OII) announces that its Subsea Robotics segment won multiple contracts during the third quarter of 2022, with anticipated aggregate revenue of $300 million. These

OII

Read More
1 minute read
  • Earnings
  • News

Washington Federal Q4 EPS $1.07 Up From $0.72 YoY

By Michael Horton
October 13, 5:01 PM
Washington Federal (NASDAQ:WAFD) reported quarterly earnings of $1.07 per share. This is a 48.61 percent increase over earnings of $0.72 per share from the same period last year.

WAFD

Read More
1 minute read
  • M&A
  • News

FCPT Announces Acquisition Of Advance Auto Parts Property For $715K

By Michael Horton
October 13, 4:56 PM
Four Corners Property Trust (NYSE:FCPT), a real estate investment trust primarily engaged in the ownership and acquisition of high-quality, net-leased restaurant and retail properties ("FCPT" or the

FCPT

Read More
1 minute read
  • Commodities
  • Government
  • Markets
  • News

Aloca Says Lobbying White House To Block U.S. Imports Of Russian Aluminum, Says Would Support U.S. Sanctions On Russian Aluminum Industry, Says Asked LME To Delist Russian Aluminum Which Co. Says Disproportionately Affects Aluminum Contract

By Michael Horton
October 13, 4:54 PM
-Reuters

AA

Read More
4 minute read
  • Guidance
  • News

Ring Energy Provides Operational Update, Lowered Fourth Quarter Capital Expenditure Guidance, Issued FY23 Capital Expenditure Guidance

By Michael Horton
October 13, 4:50 PM
Ring Energy, Inc. (NYSE:REI) ("Ring" or the "Company") today provided an operational update for the third quarter and full year 2022, revised guidance for the fourth

REI

Read More
1 minute read
  • FDA
  • News

Reata Pharmaceuticals Announces FDA Does Not Plan To Hold Advisory Committee Meeting To Discuss The NDA For Omaveloxolone For Friedreich’s Ataxia

By Michael Horton
October 13, 4:38 PM
Reata Pharmaceuticals, Inc. (NASDAQ:RETA) ("Reata," the "Company," "our," "us," or "we"), a clinical-stage biopharmaceutical company, announced that the U.S. Food

RETA

Posts pagination

Previous 1 … 133 134 135 … 211 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service